Related Experiment Video
Updated: Nov 12, 2025

Author Spotlight: Assessment of Environmental and Drug-Induced Behavioral Changes in Adult Zebrafish
Published on: November 3, 2023
[Organ-Specific Accumulation and Toxicokinetics of Ephedrine in Adult Zebrafish (Danio rerio)]
Xing-Xing Yin1,2,3, Chang-Sheng Guo1,3, Yang-Hui Deng1,3
1Center for Environmental Health Risk Assessment and Research, Chinese Research Academy of Environmental Sciences, Beijing 100012, China.
Abstract:
Ephedrine (EPH) is an alkaloid commonly used to relieve nasal congestion caused by colds, allergic rhinitis, rhinitis, and sinusitis, and to control bronchial asthma. It is also be used as a raw material in the manufacture of methamphetamine. Although the distribution of EPH in surface waters has been widely studied, its uptake, internal distribution, and toxicokinetic processing in exposed organisms have not been well investigated. In this study, we investigated the uptake, disposition, and toxicokinetics of EPH in zebrafish (Danio rerio) in a semi-static exposure system. EPH was consistently detected in zebrafish biological samples, with the highest concentrations of 84.97 ng·g-1 detected in the brain tissue of fish in the high treatment group. Over the 14-d exposure period, the relative abundance of mean concentrations of EPH in biological samples generally followed the order of brain > ovary > liver > intestine > muscle. The uptake rate constants (Ku), elimination rate constants (Ke), and half-lives of EPH in the biological tissues were in the ranges 0.23-570.31 L·(kg·d)-1, 1.22-6.11 d-1, and 0.12-0.57 d, respectively. The observed bioconcentration factor (BCFo) and kinetically-derived bioconcentration factor (BCFk) were similar, ranging 0.24-337.33 L·kg-1 and 0.13-316.43 L·kg-1, respectively. These results are helpful for understanding the behavior of psychoactive substances in aquatic organisms and have directive significance for studying their toxicity and ecological risks to aquatic organisms.
Related Concept Videos
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Drug Distribution: Tissue Binding
For...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Pharmacokinetics in Pediatric Patients: Drug Distribution

